Multi-omics profiling highlights RPLP0 as a potential biomarker for prognosis and response to immunotherapy in clear cell renal cell carcinoma. Wang B, Liu H, Guo Y, Ma J, et al. BMC Cancer 2026;26:1252.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang B, Liu H, Guo Y, Ma J, et al. Multi-omics profiling highlights RPLP0 as a potential biomarker for prognosis and response to immunotherapy in clear cell renal cell carcinoma. BMC Cancer 2026;26:1252.
PMID: 42469699